Biote vs Cronos Group
Biote is the larger business, with $192m of revenue in fiscal 2025 against $147m for Cronos Group (1.3 times as much). Cronos Group grew faster (24.6% against -2.5%). Biote kept more of each dollar of sales as profit: a net margin of 14.1% against -6.4%.
| Latest fiscal year | BioteBTMD, 2025 | Cronos GroupCRON, 2025 |
|---|---|---|
| Revenue | $192m | $147m |
| Revenue growth | -2.5% | 24.6% |
| Net income | $27.0m | −$9.4m |
| Operating margin | 18.5% | -11.9% |
| Net margin | 14.1% | -6.4% |
| Return on equity | — | -0.9% |
| Free cash flow | $30.2m | $149,000 |
| Cash | $24.1m | $792m |
| Total debt | $103m | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | 3.6% | — |
| Share buybacks | $3.4m | $9.7m |
| Employees | 223 | 610 |
| Market value | $33.2m | $1.25bn |
| Price vs our value range | Below our value range | Below our value range |
| Moat score | 33 (Weak) | 12 (Weak) |
| Insider trades, 12 months | 2 buys, 0 sales | 0 buys, 0 sales |